Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 4 recruiting now small index

Agoraphobia clinical trials

4 of 6 indexed Agoraphobia trials are currently recruiting.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

6 US clinical trials · 4 currently recruiting · #2,866 of 28,707 conditions by registered trial count

Agoraphobia: 6 US clinical trials tracked, 4 recruiting.

Agoraphobia is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. The most active sponsor is Georgetown University, running 3 of these trials.

Enrollment posture brief

Registry condition agoraphobia

OPEN 4 | RECR 67% | LATE 0 | EARLY 0 | RANK #2866 | SPON 3

Nearest open-share peer: Adenocarcinoma of Lung (67% recruiting · 6 trials)

Agoraphobia (this)67%Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%
Open-enrollment share among volume-matched conditions near Agoraphobia

Agoraphobia lists 4 open slots (67% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Agoraphobia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Agoraphobia is recruiting above its size-band peers.

    4 of 6 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Agoraphobia research.

    Georgetown University accounts for 3 of 6 trials (50%). 4 distinct sponsors appear on at least one study for this condition label.

  3. Typical Agoraphobia enrolment sits around 180 participants.

    Median target enrolment is 180 among the 6 trials that report a genuine target (sentinel values excluded). 3 of those (50%) plan for fewer than 100 participants.

  4. Agoraphobia research is mostly interventional.

    6 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase Distribution

Phase data not available

Top Sponsors

Named interventions

Most-linked intervention names on Agoraphobia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Mindful Self-Compassion Behavioral
2 trials
McLean Anxiety Mastery Program Behavioral
1 trials
Mindfulness-Based Stress Reduction Behavioral
1 trials
Psycho-Education Behavioral
1 trials
Capnometry-Guided Respiratory Intervention Device
1 trials
Team-delivered, exposure-based CBT Behavioral
1 trials
Waitlist Behavioral
1 trials

US sites by state

Facility locations filed on Agoraphobia trials. A trial with sites in several states counts in each.

Texas 1 trials
Rhode Island 1 trials
Massachusetts 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Agoraphobia page

6 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Agoraphobia condition card totals 6 registered trials; most-linked intervention Mindful Self-Compassion; top US site state District of Columbia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.